Our News on Newswise

Newswise: 61942c08e4d31_2021 Croft_.png

Suffering from psoriasis? Blame this trio of proteins

About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds to these therapies—and...
16-Nov-2021 6:15 PM EST Add to Favorites

Newswise: 6196957d077df_2021 people small.jpg

COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

New research shows how genetic variations linked to severe cases of COVID-19 affect our immune cells. The study is one of the first in-depth look at the connections between COVID-19 severity and gene expression in many types of immune cells. This...
18-Nov-2021 1:35 PM EST Add to Favorites

Newswise: 614cd1cadbe6d_Fig. 2.png

From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape

Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates. The new research...
23-Sep-2021 3:45 PM EDT Add to Favorites

Newswise: 60f5ced76b672_T lymphocytes_yellow_sm.png

C Is for Vitamin C—a Key Ingredient for Immune Cell Function

Regulatory T cells (Tregs) help control inflammation and autoimmunity in the body. Unfortunately, it has proven difficult to find the right molecular ingredients to induce stable iTregs. A new study reports that Vitamin C and TET proteins can work...
19-Jul-2021 3:30 PM EDT Add to Favorites

Newswise: 60f0a7dfb8033_Killer_T_cells_surround_a_cancer_cell.png

Preparing T Cells for the Long Haul

In a new Nature Immunology study, researchers at La Jolla Institute for Immunology (LJI) report that T cells can be engineered to clear tumors without succumbing to T cell exhaustion.
15-Jul-2021 5:45 PM EDT Add to Favorites

Newswise: vials_variants.jpg

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants.
1-Jul-2021 2:40 PM EDT Add to Favorites

Newswise: genome_small.jpg

Hard-working Enzyme Keeps Immune Cells in Line

Researchers at La Jolla Institute for Immunology (LJI) have shed light on a process in immune cells that may explain why some people develop cardiovascular diseases. Their research, published recently in Genome Biology, shows the key role that TET...
25-Jun-2021 10:05 AM EDT Add to Favorites

Newswise: tcell_cancer_small.jpg

Many Cancer Patients May Need a Sequential One-Two Punch of Immunotherapies

New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool may explain why many cancer patients do not respond to anti-PD-1 cancer immunotherapies—also called checkpoint inhibitors. The team reports...
23-Jun-2021 1:45 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: EricaSaphire-139_p.jpg

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: 2018Dr.MatthiasvonHerrath.jpg

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Contacts

Gina Kirchweger
Chief Communications Officer
allergy immunology

gina@lji.org

858-752-6640

Jenna Hambrick
Digital Strategist

jhambrick@lji.org

858.752.6645

Madeline McCurry-Schmidt
Science Writer

madeline@lji.org

619-438-2382

Twitter

close
0.17413